Marco Lodrini

6PUBLICATIONS
43CO-AUTHORS
Medical infection agents (incl. prions)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersCellular nervous systemCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 01, 2026
Quantitative and sensitive neuroblastoma minimal residual disease detection using extrachromosomal DNA (ecDNA) breakpoints.

|Feb 13, 2026
YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells.

Marius Ludwig, Kerstin Ahrens, Annika Winkler

|Jan 06, 2025
Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma.

Jan F Hollander, Annabell Szymansky, Jasmin Wünschel

|Oct 26, 2024
Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis.

Annika Sprüssel, Takayoshi Suzuki, Naoki Miyata

|Oct 16, 2024
Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma.

Sveva Castelli, Anne Thorwarth, Claudia van Schewick

|Dec 02, 2022
A Deep Dive into the Circulating ctDNA Cosmos to Vanquish Neuroblastoma.

Hedwig E Deubzer, Kathy Astrahantseff, Marco Lodrini

Pageof 1

Frequent Collaborators

6 joint publications

Hedwig E Deubzer

6 joint publications

Kathy Astrahantseff

5 joint publications

Annabell Szymansky

4 joint publications

Johannes H Schulte